Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Int J Environ Res Public Health ; 19(18)2022 Sep 15.
Article in English | MEDLINE | ID: covidwho-2071401

ABSTRACT

Obesity is a prevalent health issue. Evidence suggests that the availability of urban nature may reduce the risks of obesity. However, several knowledge gaps remain. This study explores the relationships between the dose (distance, duration and frequency) of urban nature and demographic factors towards obesity risks among people in Thailand. A total of 111 participants in three urban and peri-urban nature locations answered a survey regarding their distance from green spaces, frequency of visits, and duration of their typical stay, as well as their socio-demographics, and waist-hip ratio (WHR). The results suggested that at least 1-2 h per typical visit to nature predicted low-risk WHR in women. Male participants are more likely to have a high-risk WHR. Increasing age predicted low-risk WHR. Spending more time in green spaces predicted lower odds of high-risk WHR, while distance did not predict the odds. This research is one of the first to study the relationship between time spent in nature and obesity, and one of the first nature and health studies conducted in Thailand. Given that Thailand is one of the countries most affected by obesity in Southeast Asia, this study is relevant and essential. Future research should explore the quality factors of the park with longer duration of stay.


Subject(s)
Obesity , Body Mass Index , Female , Humans , Male , Obesity/epidemiology , Risk , Risk Factors , Thailand/epidemiology , Waist-Hip Ratio
2.
Int J Environ Res Public Health ; 19(12)2022 06 09.
Article in English | MEDLINE | ID: covidwho-1884192

ABSTRACT

Government-level ESG (environmental, social, and governance) institutionalization and active ESG activation in the private sector are being discussed for the first time this year in Korea, spurred by increased national interest since the COVID-19 pandemic crisis and the declaration of a carbon-neutral society by 2050, and ESG discussion in many fields is spreading rapidly. In addition, global awareness of the crisis caused by environmental pollution and natural disasters has highlighted the importance of green infrastructure (GI) as a new conceptual alternative to improve public value. Based on sustainability, which is a common goal of ESG and green infrastructure, this study aimed to examine the research targets and techniques of green infrastructure from the perspective of ESG. This study selected and analyzed 98 domestic and international academic journal papers published over the past 10 years in the Web of Science academic journal database literature collection. Focusing on the research subjects, the focus on green infrastructure, and research keywords, we examined the aspects of the green infrastructure plan that have been focused on from the ESG perspective and compared domestic and international research trends. In addition, implications for how each research topic is connected to the concept of ESG according to its function and purpose were derived. By examining the domestic and international research trends of green infrastructure from the ESG perspective, we identified the need for a wider range of research on the diversity and relationship between humans and the ecological environment; policies and systems; and technical research that does not focus only on a specific field. In this regard, we intend to increase the contribution to ESG management in the public sector through the establishment of green infrastructure plans and policies in the future, as they account for a large portion of public capital.


Subject(s)
COVID-19 , Pandemics , COVID-19/epidemiology , Environment , Humans , Organizations , Republic of Korea
3.
Journal of Rheumatic Diseases ; 27(4):218-232, 2020.
Article in English | Web of Science | ID: covidwho-886238

ABSTRACT

Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working group was organized and was responsible for selecting key health questions, searching and reviewing the available literature, and formulating statements. The appropriateness of the statements was evaluated by voting panels using the modified Delphi method. Four general principles and thirteen individual recommendations were finalized through expert consensus based on the available evidence. The recommendations included preventive measures against COVID-19, medicinal treatment for stable or active SRD patients without COVID-19, medicinal treatment for SRD patients with COVID-19, and patient evaluation and monitoring. Medicinal treatments were categorized according to the status with respect to both COVID-19 and SRD. These recommendations should serve as a reference for individualized treatment for patients with SRD. As new evidence is emerging, an immediate update will be required.

5.
Korean J Intern Med ; 35(6): 1317-1332, 2020 11.
Article in English | MEDLINE | ID: covidwho-797518

ABSTRACT

Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working group was organized and was responsible for selecting key health questions, searching and reviewing the available literature, and formulating statements. The appropriateness of the statements was evaluated by voting panels using the modified Delphi method. Four general principles and thirteen individual recommendations were finalized through expert consensus based on the available evidence. The recommendations included preventive measures against COVID-19, medicinal treatment for stable or active SRD patients without COVID-19, medicinal treatment for SRD patients with COVID-19, and patient evaluation and monitoring. Medicinal treatments were categorized according to the status with respect to both COVID-19 and SRD. These recommendations should serve as a reference for individualized treatment for patients with SRD. As new evidence is emerging, an immediate update will be required.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Rheumatic Diseases/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antirheumatic Agents/therapeutic use , COVID-19 , Coronavirus Infections/diagnosis , Exercise , Humans , Pandemics , Pneumonia, Viral/diagnosis , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL